2017
PsychoGenics will carry out EEG readings of sleeping and awake ACE1 transgenic mice containing genetic variants identified by Genome-Wide Association Studies (GWAS) for their impact on Alzheimer’s disease risk. This research is being conducted in conjunction with Robert Vassar, Ph.D.’s project “Molecular and Cellular Mechanisms of ACE1 Variant in Alzheimer’s Disease.”
$27,500
Studies of Alternative Neurodegenerative Pathways, Translational
PsychoGenics
Mathieu Bourdenx, Karen Duff, | 2022
Howard L. Weiner, Laura M. Cox, | 2022
Eng H. Lo, | 2022
Se Hoon Choi, Christiane Wrann, | 2021
Scott Russo, Wolfram Poller, | 2022
Helene Benveniste, Allen Tannenbaum, | 2022
Richard Daneman, | 2022
Helene Benveniste, Allen Tannenbaum, | 2022